We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.76B
AUM Growth
+$23.6M
Cap. Flow
-$62.2M
Cap. Flow %
-3.54%
Top 10 Hldgs %
42.05%
Holding
203
New
5
Increased
64
Reduced
91
Closed
5

Top Buys

Rank Stock Value
1
RELX icon
RELX
RELX
+$15.2M
2
ULS icon
UL Solutions
ULS
+$8.94M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$6.36M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.15M
5
ALC icon
Alcon
ALC
+$5.06M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$57.6M
2
NKE icon
Nike
NKE
+$23.5M
3
CVS icon
CVS Health
CVS
+$12.4M
4
CNI icon
Canadian National Railway
CNI
+$10.5M
5
NVDA icon
NVIDIA
NVDA
+$6.84M

Sector Composition

Rank Sector Weight
1 Technology 34.37%
2 Healthcare 19.6%
3 Industrials 17.79%
4 Consumer Discretionary 9.2%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALC icon
26
Alcon
ALC
$36.4B
$23.3M 1.32%
261,143
+59,331
+29% +$5.06M
TSLA icon
27
Tesla
TSLA
$1.31T
$22.1M 1.25%
111,478
+4,453
+4% +$778K
CCK icon
28
Crown Holdings
CCK
$13.1B
$21.9M 1.24%
294,395
+17,923
+6% +$1.45M
VRT icon
29
Vertiv
VRT
$108B
$21.8M 1.24%
251,582
+5,670
+2% +$516K
TER icon
30
Teradyne
TER
$59.3B
$21M 1.19%
141,509
+2,093
+2% +$266K
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$134B
$19.9M 1.13%
42,461
+11,860
+39% +$5.15M
MKC icon
32
McCormick & Company Non-Voting
MKC
$14.2B
$19.6M 1.12%
276,853
+87,441
+46% +$6.36M
IBM icon
33
IBM
IBM
$225B
$19.3M 1.1%
111,591
+8,981
+9% +$1.56M
HD icon
34
Home Depot
HD
$353B
$19M 1.08%
55,162
+2,935
+6% +$1M
MDT icon
35
Medtronic
MDT
$116B
$17.6M 1%
223,679
-821
-0.4% -$67.3K
RELX icon
36
RELX
RELX
$61.7B
$17.2M 0.98%
375,599
+349,184
+1,322% +$15.2M
APTV icon
37
Aptiv
APTV
$10.3B
$14.7M 0.83%
208,112
+3,866
+2% +$297K
JNJ icon
38
Johnson & Johnson
JNJ
$626B
$13.2M 0.75%
90,561
-3,629
-4% -$540K
NVS icon
39
Novartis
NVS
$294B
$12.2M 0.69%
114,342
-6,878
-6% -$690K
NET icon
40
Cloudflare
NET
$109B
$12.1M 0.69%
146,678
+17,924
+14% +$1.45M
AMD icon
41
Advanced Micro Devices
AMD
$774B
$11.8M 0.67%
72,514
-2,833
-4% -$456K
ASML icon
42
ASML
ASML
$691B
$11.6M 0.66%
11,332
+6
+0.1% +$5.77K
ULS icon
43
UL Solutions
ULS
$15.6B
$9.96M 0.57%
+236,062
New +$8.94M
COST icon
44
Costco
COST
$419B
$9.58M 0.54%
11,273
+225
+2% +$176K
LLY icon
45
Eli Lilly
LLY
$1.08T
$8.2M 0.47%
9,052
-88
-1% -$70.4K
UBER icon
46
Uber
UBER
$160B
$6.68M 0.38%
91,977
+10,685
+13% +$743K
PRGO icon
47
Perrigo
PRGO
$1.78B
$6.28M 0.36%
244,707
+5,317
+2% +$156K
ABBV icon
48
AbbVie
ABBV
$442B
$6.22M 0.35%
36,267
-1,184
-3% -$196K
CRSP icon
49
CRISPR Therapeutics
CRSP
$5.23B
$6.19M 0.35%
114,673
+17,694
+18% +$1.02M
NKE icon
50
Nike
NKE
$61.3B
$5.85M 0.33%
77,560
-252,902
-77% -$23.5M
1
2
3 4 5

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return

Reynders McVeigh Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Reynders McVeigh Capital Management held 203 positions worth $1.76B, up 1.4% from $1.74B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Reynders McVeigh Capital Management withdrew a net $62.2M in Q2 2024, closing 5 positions and reducing 91 holdings. Its most notable exit was Novo Nordisk, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Reynders McVeigh Capital Management opened a new position in UL Solutions worth $9.96M.

  • Reynders McVeigh Capital Management's largest Q2 2024 buy was UL Solutions: 236,062 shares worth $9.96M.
  • Reynders McVeigh Capital Management added most to RELX in Q2 2024, an estimated $15.2M increase.
  • Reynders McVeigh Capital Management's biggest Q2 2024 reduction was Nike, cutting an estimated $23.5M.
  • Reynders McVeigh Capital Management fully exited Novo Nordisk in Q2 2024, selling an estimated $57.6M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 42% of its $1.76B portfolio in Q2 2024.
  • Reynders McVeigh Capital Management opened 5 new positions and closed 5 in Q2 2024.
  • Reynders McVeigh Capital Management's portfolio value rose 1.4% quarter-over-quarter to $1.76B.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.